-
METHODOLOGICAL CHARACTERISTICS AND QUALITY OF MODEL-BASED HEALTH ECONOMIC EVALUATIONS FOR CHRONIC HEPATITIS B
Aug 11, 2026, 17:16 PM -
OVERVIEW OF CHINA AS AN EVOLVING MAJOR PHARMACEUTICAL LAUNCH MARKET
Aug 11, 2026, 17:16 PM -
SSMC BUDGET IMPACT OF ADJUVANT TRASTUZUMAB DERUXTECAN ACROSS THE HER2-POSITIVE EARLY BREAST CANCER PATHWAY: AN AFFORDABILITY MODEL FOR UAE PAYERS
Aug 11, 2026, 17:16 PM -
CONFIGURATION OVER CONTENT: HOW LARGE LANGUAGE MODEL SETTINGS, NOT QUESTION COMPLEXITY, GOVERN REFERENCE FABRICATION IN NARRATIVE-REVIEW-STYLE OUTPUTS
Aug 11, 2026, 17:16 PM -
CROSS-COUNTRY DIFFERENCES IN REAL-WORLD LABORATORY MONITORING INTENSITY AND HEPATOTOXICITY ADVERSE EVENT DETECTION AMONG INITIATORS OF CDK4/6 INHIBITORS FOR ADVANCED BREAST CANCER
Aug 11, 2026, 17:16 PM -
COMPARING NON-CANCER-SPECIFIC SURVIVAL ESTIMATED FROM LIFETABLES AND REPORTED TRIAL DATA: A CASE STUDY FROM EARLY STAGE RESECTED MELANOMA
Aug 11, 2026, 17:16 PM -
HEALTH ECONOMIC IMPACT OF SOFTWARE-ASSISTED BRAIN MRI ON TREATMENT DECISIONS AND OUTCOMES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A MICROSIMULATION STUDY
Aug 11, 2026, 17:16 PM -
COMPARISON OF HEALTHCARE COSTS BETWEEN TOCILIZUMAB AND CONVENTIONAL IMMUNOSUPPRESSANTS IN PATIENTS WITH LARGE-VESSEL VASCULITIS: A RETROSPECTIVE STUDY USING CLAIMS DATA IN JAPAN
Aug 11, 2026, 17:16 PM -
ESTIMATING THE PARP INHIBITOR-ELIGIBLE POPULATION AND MARKET OPPORTUNITY IN OVARIAN, BREAST, AND PROSTATE CANCER ACROSS EU15
Aug 11, 2026, 17:16 PM -
INTEGRATING REAL-WORLD PHARMACOGENOMIC EVIDENCE WITH MACHINE LEARNING FOR DRUG RESPONSE PREDICTION: IMPLICATIONS FOR EQUITABLE HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND VALIDATION OF AN AI-POWERED CLINICAL PHARMACIST ASSISTANT FOR PREDICTING ADVERSE DRUG REACTIONS IN INDIAN HOSPITALS
Aug 11, 2026, 17:16 PM -
HCRU AND DIRECT MEDICAL COSTS IN COPD GOLD 2 - 3 PATIENTS: AN ANALYSIS FROM THE PERSPECTIVE OF CLINICAL EXPERTS IN MEXICO, ARGENTINA AND COLOMBIA
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC OUTCOMES OF WHOLE-BODY MRI SCREENING: A US EMPLOYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
DIGITAL THERAPEUTICS WORLDWIDE: A SCOPING REVIEW OF ADOPTION, REGULATION, REIMBURSEMENT/HTA, AND PATIENT OUTCOMES
Aug 11, 2026, 17:16 PM -
BALANCE TRAINING ON A STABILOMETRIC PLATFORM FOR TEAM ATHLETES
Aug 11, 2026, 17:16 PM -
TURNING HTA OUTCOMES INTO RELEVANT METRICS FOR SUBNATIONAL COMMISSIONING. A COPD POPULATION IMPACT MODEL FOR IMPLEMENTING NICE TA1142 AT THE LOCAL LEVEL
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT AND CARBON CONSEQUENCES OF WEARABLE CARDIOVERTER-DEFIBRILLATOR USE IN FRANCE: A TWO-COHORT ANALYSIS OF POST-AMI/ISCHEMIC HEART FAILURE AND ICD EXPLANTATION
Aug 11, 2026, 17:16 PM -
THE INCIDENCE AND PREVALENCE OF ACNE VULGARIS IN THE UNITED KINGDOM: A POPULATION-BASED ELECTRONIC HEALTH RECORD STUDY (2004-2024)
Aug 11, 2026, 17:16 PM -
COST CONSEQUENCES ANALYSIS OF OCCUPATIONAL ACCIDENT: BALANCING FEE-FOR-SERVICE MODELS WITH COST CONTAINMENT STRATEGIES
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF ERIBULIN VERSUS DACARBAZINE IN ADVANCED LIPOSARCOMA IN INDIA: A MARKOV MODEL-BASED ECONOMIC EVALUATION
Aug 11, 2026, 17:16 PM
